跳至主要内容
临床试验/NCT00852462
NCT00852462已完成2 期

Lung Cancer Symptom Assessment and Management Intervention

Dana-Farber Cancer Institute4 个研究点 分布在 1 个国家目标入组 179 人开始时间: 2008年5月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
179
试验地点
4
主要终点
% completion of intervention use and adherence to suggested symptom management strategies.

研究概览

简要总结

The purpose of this study is to develop and test the usability of a computerized symptom assessment and management intervention system in a laboratory setting (phase I) and its feasibility in a clinical setting in a group randomized trial (phase II).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HCPs: attending physician, thoracic medical oncologist, expected to work in the setting for at least 2 years.
  • Patients: 21 years of age or older; diagnosis of Stage IIIA, IIIB, IV non-small cell lung cancer OR limited or extensive stage small cell lung cancer; receiving care in the out-patient setting; receiving treatment with chemotherapy +/- additional therapies; English speaking.

排除标准

  • Patients: Any patient who needs emergent care, routine visits scheduled less than once a month

结局指标

主要结局

% completion of intervention use and adherence to suggested symptom management strategies.

时间窗: 2 years

次要结局

  • Health-related quality of life(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mary E. Cooley, Phd

Nurse Scientist

Dana-Farber Cancer Institute

研究点 (4)

Loading locations...

相似试验

Lung Cancer Symptom Assessment and Management... | 临床试验